AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1012910 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 30551161 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal relapse(s)
Number of subjects: 535
Study 30551161 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline renal function
Number of subjects: 535
Study 30551161 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term monitoring (3-monthly urinalysis)
Number of subjects: 535
Study 27155825 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal lumbar inter-body fusion (TLIF)
Number of subjects: 100
Study 27155825 — intervention group
Group type: COMPARATOR
Intervention: Posterolateral instrumented lumbar fusion (PLF)
Number of subjects: 100
Study 26347545 — intervention group
Group type: EXPERIMENTAL
Intervention: Extubation at 60°
Number of subjects: 46
Study 26347545 — intervention group
Group type: COMPARATOR
Intervention: Extubation at 90°
Number of subjects: 46
Study 23596809 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaoaiping Injection (XAP) plus best supportive treatment (BST)
Number of subjects: 68
Study 23596809 — intervention group
Group type: COMPARATOR
Intervention: Best supportive treatment (BST)
Number of subjects: 68
Study 22005564 — intervention group
Group type: EXPERIMENTAL
Intervention: Western therapy + Modified Liang‐Ge San (group L)
Number of subjects: 64
Study 22005564 — intervention group
Group type: COMPARATOR
Intervention: Western therapy only (group X)
Number of subjects: 64
Study 22005564 — intervention group
Group type: COMPARATOR
Intervention: Patients with sepsis
Number of subjects: 64
Study 19835310 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigation-assisted gap technique
Number of subjects: 46
Study 19835310 — intervention group
Group type: COMPARATOR
Intervention: Anatomic bony landmark method
Number of subjects: 46
Study 16915119 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial reteplase (0.5, 1, 1.5, and 2 units) and intravenous abciximab (0.25 mg/kg bolus followed by 0.125 mg/kg/min)
Number of subjects: 20
Study 16915119 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial reteplase and intravenous abciximab
Number of subjects: 20
Study 14669038 — intervention group
Group type: EXPERIMENTAL
Intervention: i.m. corticosteroid injection
Number of subjects: 30
Study 14669038 — intervention group
Group type: COMPARATOR
Intervention: immobilisation in a wrist splint
Number of subjects: 30
Study 10945548 — intervention group
Group type: EXPERIMENTAL
Intervention: Freehand System (neuroprosthesis)
Number of subjects: 6
Study 9299255 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber diet plan
Number of subjects: 35
Study 9299255 — intervention group
Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 35
Study 8298669 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneotherapy (mud baths or mud packs, mineral baths, electrotherapies, and gynecological exercises)
Number of subjects: 57
Study 8298669 — intervention group
Group type: COMPARATOR
Intervention: Control group (no balneotherapy)
Number of subjects: 57
Study 8298669 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneotherapy
Number of subjects: 57
Study 3115049 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiant heat supply group (n = 12)
Number of subjects: 24
Study 3115049 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 12)
Number of subjects: 24
Study 30303421 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body heat stress (WBHS) for up to 30 minutes at 73 °C
Number of subjects: 30
Study 30303421 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body heat stress (WBHS)
Number of subjects: 30
Study 26975205 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Interdisciplinary Home Rehabilitation
Number of subjects: 205
Study 26975205 — intervention group
Group type: COMPARATOR
Intervention: Conventional geriatric care and rehabilitation
Number of subjects: 205
Study 23946326 — intervention group
Group type: EXPERIMENTAL
Intervention: varenicline (1mg, twice per day for 12 weeks)
Number of subjects: 237
Study 23946326 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 237
Study 23946326 — intervention group
Group type: EXPERIMENTAL
Intervention: varenicline
Number of subjects: 237
Study 22498504 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservative-free levocabastine 0.05% ophthalmic solution
Number of subjects: 92
Study 22498504 — intervention group
Group type: COMPARATOR
Intervention: Preserved levocabastine 0.05% ophthalmic suspension
Number of subjects: 92
Study 20441832 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-slip devices
Number of subjects: 25000
Study 20441832 — intervention group
Group type: COMPARATOR
Intervention: Control Group (not using anti-slip devices)
Number of subjects: 25000
Study 17717030 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet (25 mg/day titrated up to 100 mg/day)
Number of subjects: 144
Study 17717030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 17717030 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 144
Study 15854116 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure sealants with glass ionomer
Number of subjects: 508
Study 15854116 — intervention group
Group type: COMPARATOR
Intervention: Standard package of dental health education
Number of subjects: 508
Study 12535831 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmonella typhi vaccine
Number of subjects: 8
Study 12535831 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 8
Study 11008927 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral magnesium supplements for 1 year
Number of subjects: 23
Study 11008927 — intervention group
Group type: COMPARATOR
Intervention: Control group (no magnesium supplementation)
Number of subjects: 23
Study 11008927 — intervention group
Group type: EXPERIMENTAL
Intervention: Low erythrocyte magnesium levels (< 2.3 mmol/L)
Number of subjects: 23
Study 11008927 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation
Number of subjects: 23
Study 8860762 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocal cord stripping (S)
Number of subjects: 34
Study 8860762 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 34
Study 1515974 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandostatin
Number of subjects: 41
Study 1515974 — intervention group
Group type: COMPARATOR
Intervention: Vasopressin
Number of subjects: 41
Study 6313557 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I: local tumor irradiation (approximately 4,000 cGy) combined with 'one-time' irradiation of the upper and lower half of the body, midplane dose averaging 880 cGy.
Number of subjects: 42
Study 6313557 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II: two half-body irradiation treatments through anterior-posterior fields, average dose of 800 cGy given in two fractions (600 and 200 cGy).
Number of subjects: 42
Study 6313557 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients (Group I and II) received X-ray films showing complete regression of the primary tumor.
Number of subjects: 42
Study 30449838 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized phase II trial designs
Number of subjects: 0
Study 30449838 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 25832306 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror Therapy
Number of subjects: 26
Study 25832306 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 26
Study 25832306 — intervention group
Group type: COMPARATOR
Intervention: Control (comparison between groups)
Number of subjects: 26
Study 25085073 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (L.GG)
Number of subjects: 40
Study 25085073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 22483481 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ureteric stent removal (8 days)
Number of subjects: 90
Study 22483481 — intervention group
Group type: COMPARATOR
Intervention: Routine ureteric stent removal (15 days)
Number of subjects: 90
Study 22483481 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of UTI
Number of subjects: 90
Study 20055782 — intervention group
Group type: EXPERIMENTAL
Intervention: Erdosteine (5-8 mg/kg/day)
Number of subjects: 92
Study 20055782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 18807725 — intervention group
Group type: EXPERIMENTAL
Intervention: Bee-venom therapy combined with Methotrexate, Sulfasalazine, and Meloxicam (3 months treatment)
Number of subjects: 100
Study 18807725 — intervention group
Group type: COMPARATOR
Intervention: Medication group (Methotrexate, Sulfasalazine, Meloxicam)
Number of subjects: 100
Study 15691219 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir (Levemir)
Number of subjects: 0
Study 15691219 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 0
Study 12511152 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 10797151 — intervention group
Group type: EXPERIMENTAL
Intervention: CWS to 60% of vital capacity
Number of subjects: 12
Study 10797151 — intervention group
Group type: COMPARATOR
Intervention: DS of 600 ml
Number of subjects: 12
Study 10797151 — intervention group
Group type: EXPERIMENTAL
Intervention: CWS + DS
Number of subjects: 12
Study 8656557 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (GRN) and Dexamethasone (DEX) on day 1
Number of subjects: 40
Study 8656557 — intervention group
Group type: COMPARATOR
Intervention: Granisetron (GRN) alone
Number of subjects: 40
Study 1797463 — intervention group
Group type: EXPERIMENTAL
Intervention: Gyne T* 380 Slimline
Number of subjects: 100
Study 1797463 — intervention group
Group type: COMPARATOR
Intervention: Gyne T* 380
Number of subjects: 100
Study 1797463 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices (Gyne T* 380 Slimline and Gyne T* 380)
Number of subjects: 100
Study 6137970 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 20
Study 6137970 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnomidate
Number of subjects: 20
Study 31544488 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 60
Study 31544488 — intervention group
Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 60
Study 31359463 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally fitted models of diameter-height (D:H) relationships
Number of subjects: 42627
Study 31359463 — intervention group
Group type: COMPARATOR
Intervention: Generic models (parameterized national, georegional, and pantropical equations)
Number of subjects: 42627
Study 28252842 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cell (MSC) implantation
Number of subjects: 88
Study 28252842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 28252842 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cells (BMC)
Number of subjects: 88
Study 27648618 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical stapler
Number of subjects: 120
Study 27648618 — intervention group
Group type: COMPARATOR
Intervention: Monofilament sutures
Number of subjects: 120
Study 24658550 — intervention group
Group type: EXPERIMENTAL
Intervention: VAMUF
Number of subjects: 60
Study 24658550 — intervention group
Group type: COMPARATOR
Intervention: AVMUF
Number of subjects: 60
Study 22954459 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended Internet intervention (Alcohol Help Center [AHC])
Number of subjects: 170
Study 22954459 — intervention group
Group type: COMPARATOR
Intervention: Brief Internet intervention (Check Your Drinking [CYD] screener])
Number of subjects: 170
Study 19284179 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg of valerian
Number of subjects: 37
Study 19284179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 17463353 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy enhanced with focused complicated grief components
Number of subjects: 19
Study 17463353 — intervention group
Group type: COMPARATOR
Intervention: Standard interpersonal psychotherapy
Number of subjects: 19
Study 11156086 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracoscopic, internal intercostal nerve block with 3 cc of 0.5% bupivacain at T2, T3, and T4 intercostal levels
Number of subjects: 32
Study 11156086 — intervention group
Group type: COMPARATOR
Intervention: Bilateral thoracic sympathectomy without the block
Number of subjects: 32
Study 9362354 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (2 x 10(6) KIU initially, followed by 5 x 10(5) KIU/h infusion)
Number of subjects: 80
Study 9362354 — intervention group
Group type: COMPARATOR
Intervention: Control (saline solution)
Number of subjects: 80
Study 1412680 — intervention group
Group type: EXPERIMENTAL
Intervention: Test plastic (non-DEHP plastic bag)
Number of subjects: 2
Study 1412680 — intervention group
Group type: COMPARATOR
Intervention: Control plastic (DEHP plastic bag)
Number of subjects: 2
Study 3990734 — intervention group
Group type: EXPERIMENTAL
Intervention: Strenuous exercise with weight-loss
Number of subjects: 28
Study 3990734 — intervention group
Group type: COMPARATOR
Intervention: Strenuous exercise with weight-maintenance
Number of subjects: 28
Study 3990734 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-study follow-up
Number of subjects: 28
Study 29238988 — intervention group
Group type: EXPERIMENTAL
Intervention: Plerixafor plus granulocyte-colony-stimulating factor
Number of subjects: 101
Study 29238988 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus granulocyte-colony-stimulating factor
Number of subjects: 101
Study 26395778 — intervention group
Group type: EXPERIMENTAL
Intervention: Reversed gap (RG) technique
Number of subjects: 60
Study 26395778 — intervention group
Group type: COMPARATOR
Intervention: Classical gap (GT) technique
Number of subjects: 60
Study 24626142 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training (ECC)
Number of subjects: 19
Study 24626142 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 19
Study 22271753 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 weeks of exercise training
Number of subjects: 107
Study 22271753 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 107
Study 20207331 — intervention group
Group type: EXPERIMENTAL
Intervention: Discography with pain scores
Number of subjects: 24
Study 20207331 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemical analysis of disc lavage fluid
Number of subjects: 24
Study 20207331 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI scoring for Pfirrmann grading of the lumbar discs
Number of subjects: 24
Study 20207331 — intervention group
Group type: COMPARATOR
Intervention: Control group (3 scoliosis patients without back pain)
Number of subjects: 24
Study 19143194 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (normodipine) administered as monotherapy for 12 weeks
Number of subjects: 52
Study 15814391 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal Misoprostol (50 microg)
Number of subjects: 96
Study 15814391 — intervention group
Group type: COMPARATOR
Intervention: Transcervical Foley catheters (Size 16F, 30 ml balloon)
Number of subjects: 96
Study 15814391 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal Misoprostol
Number of subjects: 96
Study 15814391 — intervention group
Group type: COMPARATOR
Intervention: Transcervical Foley catheters
Number of subjects: 96
Study 12414433 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative photoreceptor displacement
Number of subjects: 20
Study 12414433 — intervention group
Group type: COMPARATOR
Intervention: No preoperative photoreceptor displacement
Number of subjects: 20
Study 10492406 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (8.0 ml of 1.0% ropivacaine with 50 IU/ml hyaluronidase)
Number of subjects: 80
Study 10492406 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (8.0 ml of 0.75% bupivacaine with 50 IU/ml hyaluronidase)
Number of subjects: 80
Study 10492406 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 80
Study 10492406 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 80
Study 8611064 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol
Number of subjects: 0
Study 8611064 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic placebo
Number of subjects: 0
Study 1706910 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (84 micrograms administered in each nostril twice a day for 7 days)
Number of subjects: 13
Study 1706910 — intervention group
Group type: COMPARATOR
Intervention: Placebo (administered in each nostril twice a day for 7 days)
Number of subjects: 13
Study 31152545 — intervention group
Group type: EXPERIMENTAL
Intervention: Aronia whole fruit powder (12 mg, 10 g berries)
Number of subjects: 66
Study 31152545 — intervention group
Group type: EXPERIMENTAL
Intervention: Aronia extract powder (116 mg, 75 g berries)
Number of subjects: 66
Study 31152545 — intervention group
Group type: EXPERIMENTAL
Intervention: Aronia extract (day 1 consumption)
Number of subjects: 66
Study 31152545 — intervention group
Group type: EXPERIMENTAL
Intervention: Aronia extract (12 weeks later)
Number of subjects: 66
Study 31152545 — intervention group
Group type: EXPERIMENTAL
Intervention: Aronia extract
Number of subjects: 66
Study 31152545 — intervention group
Group type: EXPERIMENTAL
Intervention: Aronia whole fruit
Number of subjects: 66
Study 26431983 — intervention group
Group type: EXPERIMENTAL
Intervention: ID 15 μg HA
Number of subjects: 600
Study 26431983 — intervention group
Group type: COMPARATOR
Intervention: ID 6 μg HA
Number of subjects: 600
Study 26431983 — intervention group
Group type: COMPARATOR
Intervention: ID 9 μg HA
Number of subjects: 600
Study 26431983 — intervention group
Group type: COMPARATOR
Intervention: SC 15 μg HA
Number of subjects: 600
Study 26431983 — intervention group
Group type: EXPERIMENTAL
Intervention: ID 15 μg HA (single or two doses)
Number of subjects: 600
Study 26431983 — intervention group
Group type: COMPARATOR
Intervention: SC vaccine
Number of subjects: 600
Study 23537722 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant single‐chain factor VIII (rVIII‐SingleChain)
Number of subjects: 0
Study 23537722 — intervention group
Group type: COMPARATOR
Intervention: recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa‐FP)
Number of subjects: 0
Study 21115083 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet Change (DC) - Nutrient-dense Mediterranean diet
Number of subjects: 25
Study 21115083 — intervention group
Group type: COMPARATOR
Intervention: No Change (NC) - Control group
Number of subjects: 25
Study 21536989 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg
Number of subjects: 117
Study 21536989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 17389293 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based proactive system (PRECARES) with 2 monthly letters and follow-up calls
Number of subjects: 6665
Study 17389293 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 6665
Study 17389293 — intervention group
Group type: EXPERIMENTAL
Intervention: US mail reminder for employee subgroup
Number of subjects: 6665
Study 17389293 — intervention group
Group type: EXPERIMENTAL
Intervention: E-mail reminder for employee subgroup
Number of subjects: 6665
Study 17389293 — intervention group
Group type: COMPARATOR
Intervention: Control group for employee subgroup
Number of subjects: 6665
Study 16118910 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC)
Number of subjects: 26
Study 16118910 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 26
Study 11865836 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PXF; 400 mg, 3 times daily)
Number of subjects: 172
Study 11865836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study 10529021 — intervention group
Group type: COMPARATOR
Intervention: Hydromorphone (HYD) 0 mg
Number of subjects: 14
Study 10529021 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone (HYD) 4 mg
Number of subjects: 14
Study 10529021 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone (HYD) 8 mg
Number of subjects: 14
Study 10529021 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone (HYD) 16 mg
Number of subjects: 14
Study 10529021 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone (HYD)
Number of subjects: 14
Study 10529021 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP)
Number of subjects: 14
Study 7773850 — intervention group
Group type: EXPERIMENTAL
Intervention: Antifungal denture soaking solution (48 mL nystatin liquid, 100,000 IU/mL, dissolved in 432 mL of distilled water producing 10,000 IU nystatin/mL solution) used as an adjunct to nystatin vaginal lozenge (100,000 IU/g, dissolved in the mouth three times daily for seven days)
Number of subjects: 0
Study 7773850 — intervention group
Group type: COMPARATOR
Intervention: Antifungal denture soaking solution
Number of subjects: 0
Study 1691385 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine-ER 5 mg once daily (n = 49)
Number of subjects: 101
Study 1691385 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 52)
Number of subjects: 101
Study 6248087 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipecurium bromide
Number of subjects: 90
Study 6248087 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium bromide
Number of subjects: 90
Study 29986613 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent oxytocin infusion
Number of subjects: 200
Study 29986613 — intervention group
Group type: COMPARATOR
Intervention: Continued oxytocin infusion
Number of subjects: 200
Study 31083052 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT) plus enhanced usual care
Number of subjects: 94
Study 31083052 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (UC) alone
Number of subjects: 94
Study 27943450 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 40
Study 27943450 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 40
Study 26222998 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-stigmatizing video
Number of subjects: 72